PharmaTher
PharmaTher Holdings develops and commercializes ketamine-based pharmaceuticals aimed at treating mental health disorders such as depression and anxiety. Their approach utilizes ketamine's rapid-acting properties to provide effective therapeutic options for patients who have not responded to traditional treatments.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$7.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- PharmaTher Holdings develops and commercializes ketamine-based pharmaceuticals aimed at treating mental health disorders such as depression and anxiety. Their approach utilizes ketamine's rapid-acting properties to provide effective therapeutic options for patients who have not responded to traditional treatments.